Philip S Macklin

9PUBLICATIONS
36CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsLarge and complex data theoryPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 26, 2024
Prostate cancer detection after atypical small acinar proliferation (ASAP): A 10-year single-centre cohort.

Thineskrishna Anbarasan, Mutie Raslan, Kanchan Ghosh

|Apr 24, 2024
Publisher Correction: Semaphorin 3A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells.

Mike B Barnkob, Yale S Michaels, Violaine André

|Apr 12, 2024
Semmaphorin 3 A causes immune suppression by inducing cytoskeletal paralysis in tumour-specific CD8+ T cells.

Mike B Barnkob, Yale S Michaels, Violaine André

|Oct 09, 2021
Multiparameter persistent homology landscapes identify immune cell spatial patterns in tumors.

Oliver Vipond, Joshua A Bull, Philip S Macklin

|Feb 18, 2021
Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung Cancer.

Michael Skwarski, Daniel R McGowan, Elizabeth Belcher

|Feb 23, 2020
Recent advances in the biology of tumour hypoxia with relevance to diagnostic practice and tissue-based research.

Philip S Macklin, Atsushi Yamamoto, Lisa Browning

Pageof 2

Frequent Collaborators

4 joint publications

Joshua A Bull

3 joint publications

Christopher W Pugh

2 joint publications

Uzi Gileadi

2 joint publications

Victoria K Woodcock